Doubling time of lung cancer determined using three-dimensional volumetric software: Comparison of squamous cell carcinoma and adenocarcinoma

Lung Cancer

Volumn 66, Issue 2, 2009, Pages 211-217

  Honda, Osamu ^a   Johkoh, Takeshi ^b   Sekiguchi, Junko ^c   Tomiyama, Noriyuki ^a   Mihara, Naoki ^a   Sumikawa, Hiromitsu ^a   Inoue, Atsuo ^a   Yanagawa, Masahiro ^a   Daimon, Tadahisa ^d   Okumura, Meinoshin ^a   Nakamura, Hironobu ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Kinki Central Hospital of Mutual Association of Public School Teachers   (Japan)

^c GE HealthCare Japan   (Japan)

^d JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Adenocarcinoma; Computer assisted diagnosis; Doubling time; Lung cancer; Squamous cell carcinoma; Three dimensional volumetry

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER STAGING; CANCER SURGERY; CELL KINETICS; COMPUTER ASSISTED DIAGNOSIS; COMPUTER ASSISTED TOMOGRAPHY; COMPUTER PROGRAM; CONTROLLED STUDY; DATA ANALYSIS SOFTWARE; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; FEMALE; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; LUNG ADENOCARCINOMA; LUNG SQUAMOUS CELL CARCINOMA; LUNG SURGERY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; THREE DIMENSIONAL IMAGING; TUMOR VOLUME;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; DIAGNOSIS, COMPUTER-ASSISTED; FEMALE; HUMANS; IMAGING, THREE-DIMENSIONAL; LUNG NEOPLASMS; MALE; MIDDLE AGED; SOFTWARE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 70350343721     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2009.01.018     Document Type: Article

References (37)

1. Swensen S.J., Jett J.R., Hartman T.E., et al. CT screening for lung cancer: five-year prospective experience. Radiology 235 (2005) 259-265
2. Sone S., Li F., Yang Z.G., Honda T., et al. Results of three-year mass screening programme for lung cancer using mobile low-dose spiral computed tomography scanner. Br J Cancer 84 (2001) 25-32
3. Henschke C.I., McCauley D.I., Yankelevitz D.F., et al. Early Lung Cancer Action Project: overall design and findings from baseline screening. Lancet 354 (1999) 99-105
4. Fischbach F., Knollmann F., Griesshaber V., Freund T., Akkol E., and Felix R. Detection of pulmonary nodules by multislice computed tomography: improved detection rate with reduced slice thickness. Eur Radiol 13 (2003) 2378-2383
5. Li F., Sone S., Abe H., Macmahon H., and Doi K. Malignant versus benign nodules at CT screening for lung cancer: comparison of thin-section CT findings. Radiology 233 (2004) 793-798
6. Murakami T., Yasuhara Y., Yoshioka S., Uemura M., Mochizuki T., and Ikezoe J. Pulmonary lesions detected in population-based CT screening for lung cancer: reliable findings of benign lesions. Radiat Med 22 (2004) 287-295
7. Seemann M.D., Staebler A., Beinert T., et al. Usefulness of morphological characteristics for the differentiation of benign from malignant solitary pulmonary lesions using HRCT. Eur Radiol 9 (1999) 409-417
8. Swensen S.J., Viggiano R.W., Midthun D.E., et al. Lung nodule enhancement at CT: multicenter study. Radiology 214 (2000) 73-80
9. Vansteenkiste J.F., and Stroobants S.S. PET scan in lung cancer: current recommendations and innovation. J Thorac Oncol 1 (2006) 71-73
10. Veronesi G., Bellomi M., Veronesi U., et al. Role of positron emission tomography scanning in the management of lung nodules detected at baseline computed tomography screening. Ann Thorac Surg 84 (2007) 959-965
11. MacMahon H., Austin J.H., Gamsu G., Herold C.J., Jett J.R., Naidich D.P., Patz Jr. E.F., and Swensen S.J. Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society. Radiology 237 (2005) 395-400
12. Libby D.M., Wu N., Lee I.J., et al. CT screening for lung cancer: the value of short-term CT follow-up. Chest 129 (2006) 1039-1042
13. Yankelevitz D.F., and Henschke C.I. Does 2-year stability imply that pulmonary nodules are benign?. AJR Am J Roentgenol 168 (1997) 325-328
14. Yankelevitz D.F., Reeves A.P., Kostis W.J., Zhao B., and Henschke C.I. Small pulmonary nodules: volumetrically determined growth rates based on CT evaluation. Radiology 217 (2000) 251-256
15. Collins V.P., Loeffler R.K., and Tivey H. Observations on growth rates of human tumors. Am J Roentgenol Radium Ther Nucl Med 76 (1956) 988-1000
16. Schwartz M. A biomathematical approach to clinical tumor growth. Cancer 14 (1961) 1272-1294
17. Spratt J.S., and Spratt J.A. The prognostic value of measuring the gross linear radial growth of pulmonary metastases and primary pulmonary cancers. J Thorac Cardiovasc Surg 71 (1976) 274-278
18. Geddes D.M. The natural history of lung cancer: a review based on rates of tumour growth. Br J Dis Chest 73 (1979) 1-17
19. Bone R.C., and Balk R. Staging of bronchogenic carcinoma. Chest 82 (1982) 473-480
20. Filderman A.E., Shaw C., and Matthay R.A. Lung cancer. Part I. Etiology, pathology, natural history, manifestations, and diagnostic techniques. Invest Radiol 21 (1986) 80-90
21. Spratt J.S., Meyer J.S., and Spratt J.A. Rates of growth of human neoplasms. Part II. J Surg Oncol 61 (1996) 68-83
22. Usuda K., Saito Y., Sagawa M., et al. Tumor doubling time and prognostic assessment of patients with primary lung cancer. Cancer 74 (1994) 2239-2244
23. Hasegawa M., Sone S., Takashima S., et al. Growth rate of small lung cancers detected on mass CT screening. Br J Radiol 73 (2000) 1252-1259
24. Lindell R.M., Hartman T.E., Swensen S.J., et al. Five-year lung cancer screening experience: CT appearance, growth rate, location, and histologic features of 61 lung cancers. Radiology 242 (2007) 555-562
25. Aoki T., Nakata H., Watanabe H., et al. Evolution of peripheral lung adenocarcinomas: CT findings correlated with histology and tumor doubling time. AJR Am J Roentgenol 174 (2000) 763-768
26. Revel M.P., Bissery A., Bienvenu M., Aycard L., Lefort C., and Frija G. Are two-dimensional CT measurements of small noncalcified pulmonary nodules reliable?. Radiology 231 (2004) 453-458
27. Revel M.P., Lefort C., Bissery A., et al. Pulmonary nodules: preliminary experience with three-dimensional evaluation. Radiology 231 (2004) 459-466
28. Winer-Muram H.T., Jennings S.G., Tarver R.D., et al. Volumetric growth rate of stage I lung cancer prior to treatment: serial CT scanning. Radiology 223 (2002) 798-805
29. Marten K., and Engelke C. Computer-aided detection and automated CT volumetry of pulmonary nodules. Eur Radiol 17 (2007) 888-901
30. Jennings S.G., Winer-Muram H.T., Tann M., Ying J., and Dowdeswell I. Distribution of stage I lung cancer growth rates determined with serial volumetric CT measurements. Radiology 241 (2006) 554-563
31. Rew D.A., and Wilson G.D. Cell production rates in human tissues and tumours and their significance. Part II. Clinical data. Eur J Surg Oncol 26 (2000) 405-417
32. Kakinuma R., Ohmatsu H., Kaneko M., et al. Progression of focal pure ground-glass opacity detected by low-dose helical computed tomography screening for lung cancer. J Comput Assist Tomogr 28 (2004) 17-23
33. Revel M.P., Merlin A., Peyrard S., et al. Software volumetric evaluation of doubling times for differentiating benign versus malignant pulmonary nodules. AJR Am J Roentgenol 187 (2006) 135-142
34. Detterbeck F.C., and Gibson C.J. Turning gray: the natural history of lung cancer over time. J Thorac Oncol 3 (2008) 781-792
35. Volterrani L., Mazzei M.A., Scialpi M., et al. Three-dimensional analysis of pulmonary nodules by MSCT with Advanced Lung Analysis (ALA1) software. Radiol Med 111 (2006) 343-354
36. Das M., Mühlenbruch G., Katoh M., et al. Automated volumetry of solid pulmonary nodules in a phantom: accuracy across different CT scanner technologies. Invest Radiol 42 (2007) 297-302
37. Ravenel J.G., Leue W.M., Nietert P.J., Miller J.V., Taylor K.K., and Silvestri G.A. Pulmonary nodule volume: effects of reconstruction parameters on automated measurements-a phantom study. Radiology 247 (2008) 400-408